Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 3/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP7 | P09237 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3468778 | 0.80 | OPRD1 (0.51) | — | |
| SCHEMBL3456238 | 0.79 | GPR119 (0.35) | RORCMMP1MMP2MMP3MMP7 | |
| SCHEMBL3454502 | 0.74 | PSIP1 (0.34) | CTSCMMP1MMP2MMP3MMP7 | |
| SCHEMBL3454570 | 0.64 | NMT1 (0.33) | MMP1MMP2MMP3MMP7MMP9 | |
| SCHEMBL22324769 | 0.63 | SLC18A3 (0.48) | RORC | |
| SCHEMBL4777240 | 0.61 | GBA1 (0.54) | CNR2RORC | |
| Hydrochloric Acid SCHEMBL4773264 | 0.60 | GBA1 (0.53) | CNR2RORC | |
| SCHEMBL3072064 | 0.60 | SYK (0.44) | KCNH2RORC | |
| SCHEMBL3454499 | 0.58 | HTR6 (0.33) | RORC | |
| SCHEMBL10455034 | 0.57 | PSIP1 (0.74) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2166850-A1 | NEW HETEOCYCLIC H3 ANTAGONISTS | High Point Pharmaceuticals, LLC (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008154126-A1 | NEW HETEOCYCLIC H3 ANTAGONISTS | HIGH POINT PHARMACEUTICALS, LLC (US) | 2008-12-18 | — | — | WO | disclosed |